| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/08/2014 | CN102002372B Liquid crystal aligning agent, liquid crystal aligning film, liquid crystal display element, compound and manufacture method of the compound |
| 01/08/2014 | CN101903349B 4-(4-pyridinyl)-benzamides and application thereof as ROCK activity modulators |
| 01/08/2014 | CN101541781B Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
| 01/08/2014 | CN101516335B Formulations for benzimidazolyl pyridyl ethers |
| 01/08/2014 | CN101426772B Benzotriazine inhibitors of kinases |
| 01/07/2014 | US8625815 Vehicular rearview mirror system |
| 01/07/2014 | US8624083 Nucleic acid sequences encoding transcription factors regulating alkaloid biosynthesis and their use in modifying plant metabolism |
| 01/07/2014 | US8624032 Compound libraries made through phosphine-catalyzed annulation/Tebbe/Diels-Alder reactions |
| 01/07/2014 | US8624025 Antiviral agents |
| 01/07/2014 | US8623892 Metalloenzyme inhibitor compounds |
| 01/07/2014 | US8623884 Quinazolinedione derivatives as PARP inhibitors |
| 01/07/2014 | US8623883 4-phenylamino-quinazolin-6-yl-amides |
| 01/07/2014 | US8623877 Substituted N-heteroaryl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof |
| 01/07/2014 | US8623873 Substituted piperazines as CB1 antagonists |
| 01/07/2014 | US8623872 Quinazolinone derivatives as PARP inhibitors |
| 01/07/2014 | US8623870 Pyridazinone derivatives |
| 01/07/2014 | US8623867 Cyclic amine BACE-1 inhibitors having a benzamide substituent |
| 01/07/2014 | US8623860 Azetidine derivatives, pharmaceutical compositions and uses thereof |
| 01/07/2014 | US8623857 N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1 |
| 01/07/2014 | CA2660424C Sulfonamide compound or salt thereof |
| 01/07/2014 | CA2570999C Compounds, compositions and methods |
| 01/03/2014 | WO2014005129A1 Cyanoguanidines and their use as antiviral agents |
| 01/03/2014 | WO2014004416A1 Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug |
| 01/03/2014 | WO2014004230A1 Dimethyl-benzoic acid compounds |
| 01/03/2014 | WO2014003440A1 A novel combination of a host compound and a dopant compound and an organic electroluminescence device comprising the same |
| 01/03/2014 | WO2014003400A1 Aripiprazole-organic acid cocrystal, preparation or composition containing same, and preparation method therefor |
| 01/03/2014 | WO2014003158A1 Indole derivative or salt thereof |
| 01/03/2014 | WO2014003124A1 Novel amide derivative and salt thereof |
| 01/03/2014 | WO2014002871A1 Electron transport material and organic electroluminescent element using same |
| 01/03/2014 | WO2014002105A1 Compounds for the treatment of dyslipidemia and other diseases |
| 01/03/2014 | WO2014002057A1 Pyrrolidine derivatives and their use as complement pathway modulators |
| 01/03/2014 | WO2014001802A1 2-aminopyrazine derivatives as csf-1 r kinase inhibitors |
| 01/03/2014 | WO2014001775A1 Antimicrobial compounds |
| 01/03/2014 | WO2014001281A1 A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| 01/03/2014 | WO2014001279A1 A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| 01/03/2014 | WO2014001247A1 N-[4-(Quinolin-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides as androgen receptor antagonists, production and use thereof as medicinal products |
| 01/03/2014 | WO2014000713A1 NOVEL FUSED PYRIDINE DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS |
| 01/03/2014 | WO2014000178A1 Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug |
| 01/03/2014 | CA2878049A1 Novel fused pyridine derivatives useful as c-met tyrosine kinase inhibitors |
| 01/03/2014 | CA2877786A1 N-[4-(quinolin-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides as androgen receptor antagonists, production and use thereof as medicinal products |
| 01/03/2014 | CA2877449A1 2-aminopyrazine derivatives as csf-1 r kinase inhibitors |
| 01/03/2014 | CA2877326A1 Cyanoguanidines and their use as antiviral agents |
| 01/03/2014 | CA2876993A1 Pyrrolidine derivatives and their use as complement pathway modulators |
| 01/03/2014 | CA2876778A1 A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
| 01/03/2014 | CA2876240A1 Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug |
| 01/03/2014 | CA2876157A1 Antimicrobial compounds |
| 01/03/2014 | CA2875572A1 Dimethyl-benzoic acid compounds |
| 01/02/2014 | US20140005393 Sulfonamide compounds having trpm8 antagonistic activity |
| 01/02/2014 | US20140005382 Nitrogen-containing condensed heterocyclic compound |
| 01/02/2014 | US20140005370 Molecular glasses with functionalizable groups |
| 01/02/2014 | US20140005231 Fungicidal heterocyclic carboxamides |
| 01/02/2014 | US20140005230 Fungicide hydroximoyl-tetrazole derivatives |
| 01/02/2014 | US20140005227 Carboxamide compounds and their use as calpain inhibitors v |
| 01/02/2014 | US20140005225 Method of inhibiting c-kit kinase |
| 01/02/2014 | US20140005222 Dimethyl-benzoic acid compounds |
| 01/02/2014 | US20140005221 Ring-fused compound |
| 01/02/2014 | US20140005214 Piperidinone carboxamide spirohydantoin cgrp receptor antagonists |
| 01/02/2014 | US20140005212 Substituted Pyridines as Sodium Channel Blockers |
| 01/02/2014 | US20140005211 Derivatives of pyrazole-substituted amino-heteroaryl compounds |
| 01/02/2014 | US20140005195 Bipyridine sulfonamide derivatives for the treatment of neurodegenerative diseases or conditions |
| 01/02/2014 | US20140005194 Benzimidazole derivatives: preparation and pharmaceutical applications |
| 01/02/2014 | US20140005182 Aryl Methyl Benzoquinazolinone M1 Receptor Positive Allosteric Modulators |
| 01/02/2014 | US20140005180 Phenyl amino pyrimidine compounds and uses thereof |
| 01/02/2014 | US20140005177 Pyridinyl- and pyrazinyl-methyloxy-aryl derivatives useful as inhibitors of spleen tyrosine kinase (syk) |
| 01/02/2014 | US20140005176 2-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders |
| 01/02/2014 | US20140005174 Indole derivatives useful as ccr2 antagonists |
| 01/02/2014 | US20140005167 Kinase inhibitors and method of treating cancer with same |
| 01/02/2014 | US20140005165 Substituted 3-azabicyclo[3.1.0]hexane derivatives useful as ccr2 antagonists |
| 01/02/2014 | US20140005164 Wnt pathway antagonists |
| 01/02/2014 | US20140005150 3,4-diarylpyrazoles as protein kinase inhibitors |
| 01/02/2014 | US20140005143 Substituted PyridineCompound |
| 01/02/2014 | US20140004174 Selective inhibitors of histone deacetylase |
| 01/02/2014 | US20140001460 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same |
| 01/01/2014 | EP2679587A1 Compounds having bipyridyl group and carbazole ring, and organic electroluminescent element |
| 01/01/2014 | EP2679586A1 Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same |
| 01/01/2014 | EP2679585A1 Glycine transport inhibitor |
| 01/01/2014 | EP2679583A1 Mesoionic pesticides |
| 01/01/2014 | EP2678332A2 Diaminopyrimidine derivatives and processes for the preparation thereof |
| 01/01/2014 | EP2678331A2 Diaminopyrimidine derivatives and processes for the preparation thereof |
| 01/01/2014 | EP2678329A1 Triazolopyridine compounds as pim kinase inhibitors |
| 01/01/2014 | EP2678318A1 Cannabinoid receptor modulators |
| 01/01/2014 | EP2678315A2 (PYRIDIN-4-YL)BENZYLAMIDES AS ALLOSTERIC MODULATORS OF ALPHA 7 nAChR |
| 01/01/2014 | CN103492378A Novel pesticidal pyrazole compounds |
| 01/01/2014 | CN103492377A Triazolopyridine compounds as PIM kinase inhibitors |
| 01/01/2014 | CN103492376A Bicyclic heterocycle compounds and their uses in therapy |
| 01/01/2014 | CN103492375A Pyrazole derivatives, preparation method thereof, and composition for preventing and treating osteoporosis containing same |
| 01/01/2014 | CN103492374A Pyrazolidin-3-one derivatives |
| 01/01/2014 | CN103492373A Ethynyl derivatives as positive allosteric modulators of the MGLUR5 |
| 01/01/2014 | CN103492372A Androgen receptor modulating carboxamides |
| 01/01/2014 | CN103492370A Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith |
| 01/01/2014 | CN103492369A Cannabinoid receptor modulators |
| 01/01/2014 | CN103492366A Primary amine diazeniumdiolate heterocyclic derivatives |
| 01/01/2014 | CN103483376A Technology of extracting co-produced fytic acid and nicotine from tobacco waste |
| 01/01/2014 | CN103483345A Phosphoinositide 3-kinase (P13K) inhibitor, pharmaceutical composition containing P13K inhibitor, and application of phosphoinositide kinase inhibitor and pharmaceutical composition |
| 01/01/2014 | CN103483322A 5-fluoro-1H-benzimidazole-4-formamide derivatives, as well as preparation method and medical application thereof |
| 01/01/2014 | CN103483321A Alkyl linked pyridoin-quinolinone compounds and preparation method as well as application thereof |
| 01/01/2014 | CN103483320A Synthetic method of Rabeprazole Sulfone (2-[[[4-(3-methoxy propoxy)-3-methyl-2-pyridyl] methyl] sulfonyl]-1H-benzimidazole) |
| 01/01/2014 | CN103483319A Spiro substituted compounds as angiogenesis inhibitors |
| 01/01/2014 | CN103483318A Environment-friendly novel technology for synthesizing high content nicosulfuron |
| 01/01/2014 | CN103483317A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |